Arterial spin-labeling MR imaging of renal masses: Correlation with histopathologic findings

Radiology

Volumn 265, Issue 3, 2012, Pages 799-808

  Lanzman, Rotem S ^a   Robson, Phil M ^b   Sun, Maryellen R ^c   Patel, Amish D ^c   Mentore, Kimiknu ^c   Wagner, Andrew A ^c   Genega, Elizabeth M ^c   Rofsky, Neil M ^d   Alsop, David C ^c   Pedrosa, Ivan ^c,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERIAL SPIN LABELING; ARTICLE; CHROMOPHOBE RENAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PERFUSION; KIDNEY TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOCYTOMA; PAPILLARY RENAL CELL CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPIN LABELING; TUMOR CLASSIFICATION;

ADENOMA, OXYPHILIC; ANALYSIS OF VARIANCE; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPIN LABELS;

EID: 84870031653     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112260     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57(1):43-66. (Pubitemid 46148091)
2. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27(5):612-624. (Pubitemid 36514472)
3. Schrader AJ, Olbert PJ, Hegele A, Varga Z, Hofmann R. Metastatic non-clear cell renal cell carcinoma: current therapeutic options. BJU Int 2008;101(11):1343-1345. (Pubitemid 351623979)
4. Schmidbauer J, Remzi M, Memarsadeghi M, et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 2008;53(5):1003-1011.
5. Richter F, Kasabian NG, Irwin RJ Jr, Watson RA, Lang EK. Accuracy of diagnosis by guided biopsy of renal mass lesions classified indeterminate by imaging studies. Urology 2000;55(3):348-352. (Pubitemid 30110582)
6. Blumenfeld AJ, Guru K, Fuchs GJ, Kim HL. Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade. Urology 2010;76(3):610-613.
7. Adey GS, Pedrosa I, Rofsky NM, Sanda MG, DeWolf WC. Lower limits of detection using magnetic resonance imaging for solid components in cystic renal neoplasms. Urology 2008;71(1):47-51. (Pubitemid 351173276)
8. Ho VB, Allen SF, Hood MN, Choyke PL. Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology 2002;224(3):695-700. (Pubitemid 34919800)
9. Yoshimitsu K, Irie H, Tajima T, et al. MR imaging of renal cell carcinoma: its role in determining cell type. Radiat Med 2004;22(6):371-376. (Pubitemid 40144012)
10. Pedrosa I, Chou MT, Ngo L, et al. MR classification of renal masses with pathologic correlation. Eur Radiol 2008;18(2):365-375. (Pubitemid 351234058)
11. Sun MR, Ngo L, Genega EM, et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes - correlation with pathologic findings. Radiology 2009;250(3):793-802.
12. Palmowski M, Schifferdecker I, Zwick S, et al. Tumor perfusion assessed by dynamic contrast-enhanced MRI correlates to the grading of renal cell carcinoma: initial results. Eur J Radiol 2010;74(3):e176-e180.
13. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002;47(3):601-606. (Pubitemid 34194016)
14. Alsop DC, Detre JA. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998;208(2):410-416. (Pubitemid 28373748)
15. Martirosian P, Klose U, Mader I, Schick F. FAIR true-FISP perfusion imaging of the kidneys. Magn Reson Med 2004;51(2):353-361. (Pubitemid 38168595)
16. Fenchel M, Martirosian P, Langanke J, et al. Perfusion MR imaging with FAIR true FISP spin labeling in patients with and without renal artery stenosis: initial experience. Radiology 2006;238(3):1013-1021. (Pubitemid 43289934)
17. Lanzman RS, Wittsack HJ, Martirosian P, et al. Quantification of renal allograft perfusion using arterial spin labeling MRI: initial results. Eur Radiol 2010;20(6):1485-1491.
18. Pedrosa I, Rafatzand K, Robson P, et al. Arterial spin labeling MR imaging for characterisation of renal masses in patients with impaired renal function: initial experience. Eur Radiol 2012;22(2):484-492.
19. Barrett T, Brechbiel M, Bernardo M, Choyke PL. MRI of tumor angiogenesis. J Magn Reson Imaging 2007;26(2):235-249. (Pubitemid 47257720)
20. Noguchi T, Yoshiura T, Hiwatashi A, et al. Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol 2008;29(4):688-693. (Pubitemid 351571547)
21. Kimura H, Takeuchi H, Koshimoto Y, et al. Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. AJNR Am J Neuroradiol 2006;27(1):85-93. (Pubitemid 46939891)
22. de Bazelaire C, Alsop DC, George D, et al. Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res 2008;14(17):5548-5554.
23. Schor-Bardach R, Alsop DC, Pedrosa I, et al. Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? Radiology 2009;251(3):731-742.
24. Boss A, Martirosian P, Schraml C, et al. Morphological, contrast-enhanced and spin labeling perfusion imaging for monitoring of relapse after RF ablation of renal cell carcinomas. Eur Radiol 2006;16(6):1226-1236. (Pubitemid 43834708)
25. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology 1996;201(3):705-710. (Pubitemid 26392618)
26. Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60(6):1488-1497.
27. Robson PM, Madhuranthakam AJ, Dai W, Pedrosa I, Rofsky NM, Alsop DC. Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling. Magn Reson Med 2009;61(6):1374-1387.
28. Roberts DA, Detre JA, Bolinger L, et al. Renal perfusion in humans: MR imaging with spin tagging of arterial water. Radiology 1995;196(1):281-286.
29. Chalela JA, Alsop DC, Gonzalez-Atavales JB, Maldjian JA, Kasner SE, Detre JA. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000;31(3):680-687. (Pubitemid 30131655)
30. Bydder M, Larkman DJ, Hajnal JV. Combination of signals from array coils using image-based estimation of coil sensitivity profiles. Magn Reson Med 2002;47(3):539-548. (Pubitemid 34194009)
31. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997;10(6):537-544. (Pubitemid 27293491)
32. Reuter VE, Presti JC Jr. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol 2000;27(2):124-137. (Pubitemid 30205368)
33. Gilad AA, Israely T, Dafni H, Meir G, Cohen B, Neeman M. Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: the role of stroma cells in tumor angiogenesis. Int J Cancer 2005;117(2):202-211. (Pubitemid 41377439)
34. Hahn OM, Yang C, Medved M, et al. Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol 2008;26(28):4572-4578.
35. Taouli B, Thakur RK, Mannelli L, et al. Renal lesions: characterization with diffusionweighted imaging versus contrast-enhanced MR imaging. Radiology 2009;251(2):398-407.
36. Mertz KD, Demichelis F, Kim R, et al. Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. Hum Pathol 2007;38(10):1454-1462. (Pubitemid 47418973)
37. Minardi D, Lucarini G, Filosa A, et al. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up. Int J Immunopathol Pharmacol 2008;21(2):447-455. (Pubitemid 351988410)
38. Scialpi M, Di Maggio A, Midiri M, Loperfido A, Angelelli G, Rotondo A. Small renal masses: assessment of lesion characterization and vascularity on dynamic contrastenhanced MR imaging with fat suppression. AJR Am J Roentgenol 2000;175(3):751-757.
39. Zhang J, Lefkowitz RA, Ishill NM, et al. Solid renal cortical tumors: differentiation with CT. Radiology 2007;244(2):494-504. (Pubitemid 47080882)
40. Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001;32(6):590-595. (Pubitemid 32601240)
41. Sengupta S, Lohse CM, Leibovich BC, et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 2005;104(3):511-520. (Pubitemid 41022807)
42. Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 2010;195(6):W421-W427.
43. Lebret T, Poulain JE, Molinie V, et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 2007;178(4 Pt 1):1184-1188; discussion 1188.